Liaoning Chengda Biotechnology Co (SHSE:688739) Accounts Payable & Accrued Expense : ¥373 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Liaoning Chengda Biotechnology Co Accounts Payable & Accrued Expense?

Liaoning Chengda Biotechnology Co's quarterly accounts payable & accrued expense increased from Mar. 2024 (¥318 Mil) to Jun. 2024 (¥369 Mil) and increased from Jun. 2024 (¥369 Mil) to Sep. 2024 (¥373 Mil).

Liaoning Chengda Biotechnology Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥281 Mil) to Dec. 2022 (¥268 Mil) but then increased from Dec. 2022 (¥268 Mil) to Dec. 2023 (¥350 Mil).

Liaoning Chengda Biotechnology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Liaoning Chengda Biotechnology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liaoning Chengda Biotechnology Co Accounts Payable & Accrued Expense Chart

Liaoning Chengda Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

176.11

224.21

281.42

268.29

349.95

Liaoning Chengda Biotechnology Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															351.62	349.95	318.11	369.01	373.38

Liaoning Chengda Biotechnology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Liaoning Chengda Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liaoning Chengda Biotechnology Co Ltd (SHSE:688739) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179

Website

http://www.cdbio.cn

Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.

Executives

Li Ning	Director
Cui Jian Wei	senior management
Chen Xin	senior management
Zhang Shu Min	Director
Zhou Li Bao	senior management
Yuan De Ming	senior management
Gao Jun	Director
Yang Xu	Director

Liaoning Chengda Biotechnology Co Headlines

No Headlines